MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 1187990-87-9
MCE 国际站:MK-8617
产品活性:MK-8617 是一种低氧诱导因子脯氨酰羟化酶 1-3 (HIF PHD1-3) 的口服活性泛抑制剂,对于 PHD2 的 IC50 值为 1 nM。
研究领域:Metabolic Enzyme/Protease
作用靶点:HIF/HIF Prolyl-Hydroxylase
In Vitro: MK-8617 is an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) with an IC50 of 1 nM for PHD2. MK-8617 is not a significant inhibitor of the cytochrome p450 enzymes in vitro (IC50), CYP1A2, 3A4, 2B6, 2C9, 2C19, or 2D6, >60 μM, and is a moderate reversible inhibitor of CYP2C8 at 1.6 μM in vitro. The IC50 of MK-8617 is determined for factor inhibiting HIF (FIH) to be 18 μM.
In Vivo: Tritiated MK-8617 exhibits minimal metabolic turnover in liver microsomes from rat, dog, and monkey (<10% turover) but significant turnover in human liver microsomes (34% turnover) after 60 min (10 μM MK-8617, 1 mg/mL microsomal protein). In terms of its pharmacokinetic profile, MK-8617 shows good oral bioavailability across species (36 to 71%), with low clearance and volume of distribution. After 48 h treatment of MK-8617, postdose recovery of the radioactivity is about 26% bile, 12% urine, and 38% in feces, indicating that ~38% of the MK-8617 is absorbed and eliminated into bile and urine which is consistent with the oral bioavailability (~36%) observed in the rat study. MK-8617 also elicits an increase in erythropoietin (EPO) levels with a mouse MED of 1.5 mpk when dosed iv.
相关产品:Bioactive Compound Library Plus | Epigenetics Compound Library | Immunology/Inflammation Compound Library | Metabolism/Protease Compound Library | Reprogramming Compound Library | Oxygen Sensing Compound Library | Orally Active Compound Library | Glutamine Metabolism Compound Library | Anti-Breast Cancer Compound Library | Anti-Cancer Metabolism Compound Library | Angiogenesis-Related Compound Library | Transcription Factor-Targeted Library | Targeted Diversity Library | Cancer Stem Cells Compound Library | Heterocyclic Compound Library | HIF-2α-IN-8 | Glucosamine sulfate | HIF1-IN-3 | Threo-Chloramphenicol-d6 | Amifostine trihydrate | Albendazole | AKBA | Deferoxamine | LW6 | PT2399 | Dimethyl-bisphenol A | Ethyl 3,4-dihydroxybenzoate | Roxadustat | KG-548 | Daprodustat | 1,4-DPCA ethyl ester | AKB-6899 | 7-Hydroxyneolamellarin A | Glucosamine-13C6,15N hydrochloride | BAY 87-2243 | β,β-Dimethylacrylshikonin | PT-2385 | Adaptaquin | (Rac)-Arnebin 1 | Echinomycin | AFP464 free base | HIF-PHD-IN-1 | 1,4-DPCA
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。